CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 45 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,122,513 | -35.0% | 40,789 | -19.8% | 0.00% | -50.0% |
| Q2 2023 | $1,726,019 | +32.3% | 50,870 | +40.3% | 0.00% | +100.0% |
| Q1 2023 | $1,304,419 | -13.5% | 36,254 | +7.2% | 0.00% | -50.0% |
| Q4 2022 | $1,507,134 | +57.0% | 33,815 | -1.0% | 0.00% | +100.0% |
| Q3 2022 | $960,000 | +19.1% | 34,156 | +14.2% | 0.00% | 0.0% |
| Q2 2022 | $806,000 | -18.3% | 29,907 | +3.4% | 0.00% | 0.0% |
| Q1 2022 | $986,000 | -9.2% | 28,932 | +2.9% | 0.00% | 0.0% |
| Q4 2021 | $1,086,000 | -33.3% | 28,105 | -6.8% | 0.00% | 0.0% |
| Q3 2021 | $1,629,000 | +84.5% | 30,164 | +14.2% | 0.00% | – |
| Q2 2021 | $883,000 | -12.4% | 26,422 | -46.0% | 0.00% | -100.0% |
| Q1 2021 | $1,008,000 | -15.2% | 48,954 | -27.8% | 0.00% | 0.0% |
| Q4 2020 | $1,189,000 | +1950.0% | 67,792 | +92.0% | 0.00% | – |
| Q1 2020 | $58,000 | – | 35,317 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|